OBJECTIVE: In animal models, early life exposure to major environmental challenges such as malnutrition and stress results in persisting cardiometabolic, neuroendocrine and affective effects. While such effects have been associated with pathogenesis, the widespread occurrence of 'developmental programming' suggests it has adaptive function. Glucocorticoids may mediate 'programming' and their metabolism is known to be affected by early life events in rodents. To examine these relationships in humans, cortisol metabolism and cardiometabolic disease manifestations were examined in Holocaust survivors in relation to age at exposure and affective dysfunction, notably lifetime posttraumatic stress disorder (PTSD). METHODS: Fifty-one Holocaust survivors and 22 controls without Axis I disorder collected 24-h urine samples and were evaluated for psychiatric disorders and cardiometabolic diagnoses. Corticosteroids and their metabolites were assayed by gas chromatography-mass spectroscopy (GC-MS); cortisol was also measured by radioimmunoassay (RIA). RESULTS: Holocaust survivors showed reduced cortisol by RIA, and decreased levels of 5alpha-tetrahydrocortisol (5alpha-THF) and total glucocorticoid production by GC-MS. The latter was associated with lower cortisol metabolism by 5alpha-reductase and 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type-2. The greatest decrements were associated with earliest age of Holocaust exposure and less severe PTSD symptomatology. Cardiometabolic manifestations were associated with decreased 11beta-HSD-2 activity. In controls, 5alpha-reductase was positively associated with trauma-related symptoms (i.e., to traumatic exposures unrelated to the Holocaust). CONCLUSION: Extreme malnutrition and related stress during development is associated with long-lived alterations in specific pathways of glucocorticoid metabolism. These effects may be adaptive and link with lower risks of cardiometabolic and stress-related disorders in later life.
OBJECTIVE: In animal models, early life exposure to major environmental challenges such as malnutrition and stress results in persisting cardiometabolic, neuroendocrine and affective effects. While such effects have been associated with pathogenesis, the widespread occurrence of 'developmental programming' suggests it has adaptive function. Glucocorticoids may mediate 'programming' and their metabolism is known to be affected by early life events in rodents. To examine these relationships in humans, cortisol metabolism and cardiometabolic disease manifestations were examined in Holocaust survivors in relation to age at exposure and affective dysfunction, notably lifetime posttraumatic stress disorder (PTSD). METHODS: Fifty-one Holocaust survivors and 22 controls without Axis I disorder collected 24-h urine samples and were evaluated for psychiatric disorders and cardiometabolic diagnoses. Corticosteroids and their metabolites were assayed by gas chromatography-mass spectroscopy (GC-MS); cortisol was also measured by radioimmunoassay (RIA). RESULTS: Holocaust survivors showed reduced cortisol by RIA, and decreased levels of 5alpha-tetrahydrocortisol (5alpha-THF) and total glucocorticoid production by GC-MS. The latter was associated with lower cortisol metabolism by 5alpha-reductase and 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type-2. The greatest decrements were associated with earliest age of Holocaust exposure and less severe PTSD symptomatology. Cardiometabolic manifestations were associated with decreased 11beta-HSD-2 activity. In controls, 5alpha-reductase was positively associated with trauma-related symptoms (i.e., to traumatic exposures unrelated to the Holocaust). CONCLUSION:Extreme malnutrition and related stress during development is associated with long-lived alterations in specific pathways of glucocorticoid metabolism. These effects may be adaptive and link with lower risks of cardiometabolic and stress-related disorders in later life.
Authors: J L Yau; J Noble; C J Kenyon; C Hibberd; Y Kotelevtsev; J J Mullins; J R Seckl Journal: Proc Natl Acad Sci U S A Date: 2001-03-27 Impact factor: 11.205
Authors: E Rask; T Olsson; S Söderberg; R Andrew; D E Livingstone; O Johnson; B R Walker Journal: J Clin Endocrinol Metab Date: 2001-03 Impact factor: 5.958
Authors: Alexandra M Johnstone; Peter Faber; Ruth Andrew; Eileen R Gibney; Marinos Elia; Gerald Lobley; R James Stubbs; Brian R Walker Journal: Eur J Endocrinol Date: 2004-02 Impact factor: 6.664
Authors: Paula J Brunton; Marcio V Donadio; Song T Yao; Mike Greenwood; Jonathan R Seckl; David Murphy; John A Russell Journal: J Neurosci Date: 2015-01-14 Impact factor: 6.167
Authors: Ann M Rasmusson; Matthew W King; Ivan Valovski; Kristin Gregor; Erica Scioli-Salter; Suzanne L Pineles; Mohamed Hamouda; Yael I Nillni; George M Anderson; Graziano Pinna Journal: Psychoneuroendocrinology Date: 2018-11-22 Impact factor: 4.905
Authors: Patricia R Braun; Mai Tanaka-Sahker; Aubrey C Chan; Sydney S Jellison; Mason J Klisares; Benjamin W Hing; Yaseen Shabbir; Lindsey N Gaul; Yasunori Nagahama; Julian Robles; Jonathan T Heinzman; Sayeh Sabbagh; Ellyn M Cramer; Gabrielle N Duncan; Kumi Yuki; Liesl N Close; Brian J Dlouhy; Matthew A Howard; Hiroto Kawasaki; Kyle M Stein; James B Potash; Gen Shinozaki Journal: Psychiatry Clin Neurosci Date: 2019-03-28 Impact factor: 5.188
Authors: Charles F Gillespie; Lynn M Almli; Alicia K Smith; Bekh Bradley; Kimberly Kerley; Daniel F Crain; Kristina B Mercer; Tamara Weiss; Justine Phifer; Yilang Tang; Joseph F Cubells; Elisabeth B Binder; Karen N Conneely; Kerry J Ressler Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2013-03-15 Impact factor: 3.568
Authors: David Q Stoye; Ruth Andrew; William A Grobman; Emma K Adam; Pathik D Wadhwa; Claudia Buss; Sonja Entringer; Gregory E Miller; James P Boardman; Jonathan R Seckl; Lauren S Keenan-Devlin; Ann E B Borders; Rebecca M Reynolds Journal: J Clin Endocrinol Metab Date: 2020-03-01 Impact factor: 5.958